Australia’s trusted immunisation experts
28 June 2024 | NewsCall for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccinationRead the full article
Use of high-dose influenza vaccine versus standard dose influenza vaccine in adults aged ≥65 years
Use of high-dose influenza vaccine versus adjuvanted influenza vaccine in adults aged ≥65 years
Use of adjuvanted influenza vaccine versus standard dose influenza vaccine in adults aged ≥65 years
Use of MDCK cell-derived influenza vaccine versus standard dose egg-based influenza vaccine in children aged 2–17 years
Use of MDCK cell-derived influenza vaccine versus standard dose egg-based influenza vaccine in people aged ≥18 years
Compared with standard dose influenza vaccine in people aged ≥65 years
Compared with adjuvanted influenza vaccine for people aged ≥65 years
Compared with standard dose influenza vaccine in adults aged ≥65 years
Compared with standard dose egg-based influenza vaccine in children aged 2–17 years
Compared with standard dose egg-based influenza vaccine in people aged ≥18 years
Note: These GRADE documents should be read as a supplement to Australian Immunisation Handbook recommendations.
View the Influenza disease chapter in the Handbook hereView the ATAGI advice on seasonal influenza vaccines in 2023 here